Mizoribine

Mizoribine
	File:Mizoribine.png
Systematic (IUPAC) name
	5-hydroxy-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide
Clinical data
Routes of; administration	Oral
Legal status
Legal status	℞ (Prescription only);
Identifiers
CAS Number	50924-49-7
ATC code	none
PubChem	CID 104762
Synonyms	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide
Chemical data
Formula	C9H13N3O6
Molar mass	259.21 g/mol[[Script error: No such module "String".]]
	Script error: No such module "collapsible list".

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Mizoribine (INN, trade name Bredinin) is an immunosuppresive drug. The compound was first observed in Tokyo, Japan, in 1971.^[1] It is a natural product, first isolated from the mould Eupenicillium brefeldianum.

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

40px	This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. v d e

↑ Hiroaki Ishikawa (1999). "Mizoribine and Mycophenolate Mofetil". Current Medicinal Chemistry. Bentham Science: 575–597.